TBIO - トランスジェノミック (Translate Bio Inc.)

TBIOのニュース

   Telesis Bio gets $28 million in financing through preferred stock private placement  2023/05/31 21:57:17 Seeking Alpha
Telesis Bio (NASDAQ:TBIO) said Wednesday it has signed an agreement with institutional investors to provide the company with funding of $28.0 million through a private placement of…
   Telesis Bio Announces First Commercial Shipment of BioXp Select DNA Cloning Kit  2023/05/22 16:00:00 Wallstreet:Online
New Kit Enables Automation of DNA Cloning on the BioXp System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp Automated Molecular Biology Workstation SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its BioXp
   Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit  2023/05/22 16:00:00 GlobeNewswire
New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation
   Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit  2023/05/18 14:00:00 GlobeNewswire
New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation
   Telesis Bio Announces First Commercial Shipment of BioXp NGS Library Prep Kit  2023/05/18 14:00:00 Wallstreet:Online
New Kit Enables Automation of NGS Library Prep on the BioXp System Further Expanding the Utility, Speed, and Impact of the BioXp Automated Molecular Biology Workstation SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its BioXp NGS Library Prep kit for
   Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket  2023/03/22 12:07:20 Benzinga
Gainers Virgin Orbit Holdings, Inc. (NASDAQ: VORB ) shares rose 81.2% to $0.8032 in pre-market trading. Richard Branson''s Virgin Orbit is nearing a deal for a $200 million investment from Texas-based Venture Capital investor Matthew Brown via a private share placement, according to a term sheet. GameStop Corp. (NYSE: GME ) climbed 43.7% to $25.37 in pre-market trading after the company reported better-than-expected Q4 results. Diebold Nixdorf, Incorporated (NYSE: DBD ) gained 23.1% to $0.9746 in pre-market trading. Diebold Nixdorf confirms closing on $55 million of additional liquidity. Lixiang Education Holding Co., Ltd. (NASDAQ: LXEH ) gained 22.1% to $0.88 in pre-market trading after dropping 13% on Tuesday. Pyxis Oncology, Inc. (NASDAQ: PYXS ) rose 21.4% to $2.67 in pre-market after dropping around 7% on Tuesday. Blue Water Vaccines, Inc. (NASDAQ: BWV ) gained 16.2% to $1.22 in pre-market trading. Blue Water Vaccines recently posted upbeat FY22 earnings. Telesis Bio, Inc. (NASDAQ: TBIO ) shares rose 12.2% to $2.48 in pre-market trading following better-than-expected Q4 results.
   Telesis Bio Releases BioXp Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation  2023/02/16 14:00:00 Wallstreet:Online
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the availability of its BioXp Select mRNA Synthesis Kit. This kit enables on-demand and automated synthesis of mRNA beginning from a BioXp customer’s
   Alumis Expands Industry-Leading Leadership Team With Appointments of Sara Klein as General Counsel and Secretary and John R. Schroer as Chief Financial Officer  2022/04/06 11:30:00 Kwhen Finance

calendar